Dr. Camilleri’s clinical interests include gastrointestinal motility and function and appetites.
Dr. Camilleri studies gut-based gastrointestinal diseases and diseases in which conditions such as diabetes mellitus, scleroderma and neurological diseases affect the gastrointestinal tract.
The National Institutes of Health awarded Dr. Camilleri several research grants, including several R01 and American Recovery and Reinvestment Act grants.
Dr. Camilleri earned his medical degree from the University of Malta Medical School in Guardamangia and completed his residency at St. Luke’s University Hospital in Guardamangia. He underwent an internal medicine and gastroenterology fellowship at Hammersmith Hospital at the University of London.
More articles on GI & endoscopy:
PENTAX Medical names Dr. Hudson Garrett global chief clinical officer, FDA approves Gilead Sciences’ new chronic HCV drug — 6 GI company key notes
FDA approves Gilead Sciences’ Epclusa for chronic HCV: 4 observations
GI physician leader to know: Dr. Steven Shields of Atrius Health
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
